Clinical Trial Update: Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone [Phase 1]

View source ↗

Summary

Phase 1 trial update of elotuzumab in combination with lenalidomide and low-dose dexamethasone in Japanese patients with multiple myeloma has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Dexamethasone (low-dose) (dexamethasone)
• Elotuzumab (elotuzumab)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED | Results posted: 2016-01-22